Athersys Phase 2 Ischemic Stroke Clinical Trial Results to be Presented at European Stroke Conference

Athersys will release its preliminary Phase 2 ischemic stroke clinical trial (administering MultiStem®) results Sunday, April 19th at the European Stroke Organization Conference (ESOC) 2015.

Read More  >